Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Classical hematology 1

Conditions

Thromboembolism 1Thrombocytopenia 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Tinzaparin × 1 year × Clear all
NCT05284552 2026-05-11

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

University Hospital, Linkoeping

Phase 2 Recruiting
40 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT05255003 2025-12-17

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Ottawa Hospital Research Institute

Phase 4 Recruiting
50 enrolled
Classical hematology

Thrombocytopenia

NCT05625932 2025-08-22

PROTINCOL

Galician Research Group on Digestive Tumors

Phase 3 Completed
232 enrolled
Gastrointestinal

Thromboembolism, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡